GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes.

导出 LinkOut

翻译打印收藏纠错

作者： Gene I,Uenishi ^[1] ; Marko,Repic ^[1] ; Jennifer Y,Yam ^[1] ; Ashley,Landuyt ^[1] ; Priya,Saikumar-Lakshmi ^[1] ; Tingxi,Guo ^[1] ; Payam,Zarin ^[1] ; Martina,Sassone-Corsi ^[1] ; Adam,Chicoine ^[1] ; Hunter,Kellogg ^[1] ; Martina,Hunt ^[2] ; Travis,Drow ^[2] ; Ritika,Tewari ^[3] ; Peter J,Cook ^[2] ; Soo Jung,Yang ^[3] ; Karen,Cerosaletti ^[3] ; Darius,Schweinoch ^[4] ; Benjamin,Guiastrennec ^[4] ; Eddie,James ^[3] ; Chandra,Patel ^[1] ; Tiffany F,Chen ^[1] ; Jane H,Buckner ^[3] ; David J,Rawlings ^[5] ; Thomas J,Wickham ^[6] ; Karen T,Mueller ^[2]

作者单位： GentiBio Inc, Cambridge, Massachusetts, USA. ^[1] Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, Washington, USA. ^[2] Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA. ^[3] IntiQuan GmbH, Basel, Switzerland. ^[4] Department of Medicine. ^[5] Department of Immunology, and. ^[6] Department of Pediatrics, University of Washington, Seattle, Washington, USA. ^[7]

关键词 Autoimmunity Diabetes Gene therapy Therapeutics

主题词人类(Humans);小鼠(Mice);动物(Animals);糖尿病, 1型(Diabetes Mellitus, Type 1);T淋巴细胞, 调节性(T-Lymphocytes, Regulatory);自身抗原(Autoantigens);胰岛素分泌细胞(Insulin-Secreting Cells);免疫耐受(Immune Tolerance)

DOI 10.1172/jci.insight.171844

PMID 38516892

发布时间 2024-05-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JCI insight

2024年9卷6期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes.

JCI insight

相似文献

JCI insight

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes.

JCI insight

相似文献

JCI insight

相关期刊

检索历史清除